BICALUTAMIDE GT 150 MG

Bicalutamide

Public price

1.144,00 MAD

Active substance

Bicalutamide

Laboratory

ATLAS PHARM

Reimbursable

What is this medicine?

Bicalutamide is a non-steroidal androgen receptor inhibitor used for the treatment of prostate cancer.

Verified summary

Bicalutamide, Comprimé pelliculé (Retiré du marché), 150 MG, Boîte de 20

Common uses

Used in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate.

Class

Non-steroidal androgen receptor inhibitor

Laboratory

ATLAS PHARM

Availability note

Reimbursable

Strength

150 MG

Form

Comprimé pelliculé (Retiré du marché)

Presentation

Boîte de 20

Therapeutic class

Antinéoplasique, antiandrogène

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2026-06-02: 1.144,00 MAD

Available presentations and strengths

BICALUTAMIDE GT

150 MG · BOITE DE 20

1,14 MAD

BICALUTAMIDE GT

150 MG · BOITE DE 60

2,58 MAD

BICALUTAMIDE GT

50 MG · BOITE DE 20

326,00 MAD

BICALUTAMIDE GT

50 MG · 1 BOITE 20 COMPRIME PELLICULE

450,00 MAD

BICALUTAMIDE GT

50 MG · BOITE DE 30

478,00 MAD

BICALUTAMIDE GT 50 MG

50 MG · Boîte de 30

478,00 MAD

BICALUTAMIDE GT

50 MG · 1 BOITE 30 COMPRIME PELLICULE

675,00 MAD

BICALUTAMIDE GT

50 MG · BOITE DE 60

903,00 MAD

BICALUTAMIDE GT 50 MG

50 MG · Boîte de 60

903,00 MAD

BICALUTAMIDE GT

50 MG · 1 BOITE 60 COMPRIME PELLICULE

1.188,00 MAD